Morag Watson
About Morag Watson
Morag Watson is a Senior Scientist in Early Discovery Chemistry at BenevolentAI, with extensive experience in medicinal chemistry and drug discovery.
Company
Morag Watson is currently employed at BenevolentAI as a Senior Scientist in the Early Discovery Chemistry department. She contributes to early-stage drug discovery projects, leveraging her expertise in medicinal chemistry and advanced computational tools and AI technologies.
Title
Morag Watson holds the position of Senior Scientist - Early Discovery Chemistry at BenevolentAI. In this role, she is deeply involved in the design and synthesis of novel chemical compounds for therapeutic purposes.
Education and Expertise
Morag Watson obtained her MSci in Chemistry with Drug Discovery from the University of Strathclyde, where she also completed her PhD studies. She has extensive knowledge in medicinal chemistry and drug discovery processes. Additionally, she has participated in numerous collaborative research projects and presented her findings at various international conferences.
Previous Experience
Before joining BenevolentAI, Morag Watson worked at Cancer Research Technology as a Senior Scientist in Babraham, Cambridgeshire, United Kingdom from 2017 to 2021. She also served as a Postdoctoral Researcher at GSK in Stevenage, United Kingdom from 2016 to 2017. Earlier roles included a stint at Roche as an Industrial Placement Student in Basel Area, Switzerland, and involvement at EMTRAIN PhD Workshop in 2015 at Janssen Pharmaceuticals, Beerse, Belgium.
Publications and Conferences
Morag Watson has published several research papers in peer-reviewed scientific journals and frequently presents her research findings at international conferences and symposiums. Her work includes significant contributions to early-stage drug discovery and the development of novel therapeutic compounds.